These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 9845660)
1. Pharmacologic suppression of experimental abdominal aortic aneurysms: acomparison of doxycycline and four chemically modified tetracyclines. Curci JA; Petrinec D; Liao S; Golub LM; Thompson RW J Vasc Surg; 1998 Dec; 28(6):1082-93. PubMed ID: 9845660 [TBL] [Abstract][Full Text] [Related]
2. Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. Petrinec D; Liao S; Holmes DR; Reilly JM; Parks WC; Thompson RW J Vasc Surg; 1996 Feb; 23(2):336-46. PubMed ID: 8637112 [TBL] [Abstract][Full Text] [Related]
3. Suppression of experimental abdominal aortic aneurysms by systemic treatment with a hydroxamate-based matrix metalloproteinase inhibitor (RS 132908). Moore G; Liao S; Curci JA; Starcher BC; Martin RL; Hendricks RT; Chen JJ; Thompson RW J Vasc Surg; 1999 Mar; 29(3):522-32. PubMed ID: 10069917 [TBL] [Abstract][Full Text] [Related]
4. Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors. Liao S; Miralles M; Kelley BJ; Curci JA; Borhani M; Thompson RW J Vasc Surg; 2001 May; 33(5):1057-64. PubMed ID: 11331849 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines. Ramamurthy NS; Rifkin BR; Greenwald RA; Xu JW; Liu Y; Turner G; Golub LM; Vernillo AT J Periodontol; 2002 Jul; 73(7):726-34. PubMed ID: 12146531 [TBL] [Abstract][Full Text] [Related]
10. Effect of novel limited-spectrum MMP inhibitor XL784 in abdominal aortic aneurysms. Ennis T; Jin J; Bartlett S; Arif B; Grapperhaus K; Curci JA J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):417-26. PubMed ID: 22894883 [TBL] [Abstract][Full Text] [Related]
11. Doxycycline treatment in a model of early abdominal aortic aneurysm. Kaito K; Urayama H; Watanabe G Surg Today; 2003; 33(6):426-33. PubMed ID: 12768368 [TBL] [Abstract][Full Text] [Related]
12. Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms. Curci JA; Mao D; Bohner DG; Allen BT; Rubin BG; Reilly JM; Sicard GA; Thompson RW J Vasc Surg; 2000 Feb; 31(2):325-42. PubMed ID: 10664501 [TBL] [Abstract][Full Text] [Related]
13. The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms. Bigatel DA; Elmore JR; Carey DJ; Cizmeci-Smith G; Franklin DP; Youkey JR J Vasc Surg; 1999 Jan; 29(1):130-8; discussion 138-9. PubMed ID: 9882797 [TBL] [Abstract][Full Text] [Related]
14. MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial. Thompson RW; Baxter BT Ann N Y Acad Sci; 1999 Jun; 878():159-78. PubMed ID: 10415728 [TBL] [Abstract][Full Text] [Related]
15. Indomethacin prevents elastase-induced abdominal aortic aneurysms in the rat. Holmes DR; Petrinec D; Wester W; Thompson RW; Reilly JM J Surg Res; 1996 Jun; 63(1):305-9. PubMed ID: 8661215 [TBL] [Abstract][Full Text] [Related]
16. Functional importance of connective tissue repair during the development of experimental abdominal aortic aneurysms. Huffman MD; Curci JA; Moore G; Kerns DB; Starcher BC; Thompson RW Surgery; 2000 Sep; 128(3):429-38. PubMed ID: 10965315 [TBL] [Abstract][Full Text] [Related]
17. Suppression of experimental abdominal aortic aneurysms in mice by treatment with pyrrolidine dithiocarbamate, an antioxidant inhibitor of nuclear factor-kappaB. Parodi FE; Mao D; Ennis TL; Bartoli MA; Thompson RW J Vasc Surg; 2005 Mar; 41(3):479-89. PubMed ID: 15838484 [TBL] [Abstract][Full Text] [Related]
18. Controlled release of ascorbic acid from gelatin hydrogel attenuates abdominal aortic aneurysm formation in rat experimental abdominal aortic aneurysm model. Tanaka A; Hasegawa T; Morimoto K; Bao W; Yu J; Okita Y; Tabata Y; Okada K J Vasc Surg; 2014 Sep; 60(3):749-58. PubMed ID: 24011462 [TBL] [Abstract][Full Text] [Related]
19. In vivo optical molecular imaging of matrix metalloproteinase activity in abdominal aortic aneurysms correlates with treatment effects on growth rate. Sheth RA; Maricevich M; Mahmood U Atherosclerosis; 2010 Sep; 212(1):181-7. PubMed ID: 20542274 [TBL] [Abstract][Full Text] [Related]
20. Elastase is not sufficient to induce experimental abdominal aortic aneurysms. Carsten CG; Calton WC; Johanning JM; Armstrong PJ; Franklin DP; Carey DJ; Elmore JR J Vasc Surg; 2001 Jun; 33(6):1255-62. PubMed ID: 11389426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]